Freiburg's university cancer centre, known for transplant immunology, graft-versus-host disease research and PSMA-PET-guided radiotherapy.
The CCCF is a German Cancer Aid Oncology Center of Excellence and a DKTK partner site within the Medical Center, University of Freiburg. Its haematology department is a leading centre for allogeneic transplantation and for the biology and treatment of graft-versus-host disease, where Robert Zeiser's work underpinned the ruxolitinib REACH trials. Radiation oncology under Anca-Ligia Grosu pioneered PSMA-PET-guided planning for prostate cancer, and the centre runs tumour immunology, urology, gastrointestinal surgery and paediatric programmes. Freiburg's Signalling Research clusters and the Max Planck Institute of Immunobiology feed basic science into the clinic.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to University Medical Center Freiburg, including child institutions. 746 works · 6,165 citations · 65% open access · 8% clinical trials · 1% reviews.
Shares German Cancer Consortium (DKTK), Deutsches Netzwerk für Personalisierte Medizin, German Cancer Research Center (DKFZ).
Shares German Cancer Consortium (DKTK), Deutsches Netzwerk für Personalisierte Medizin, German Cancer Research Center (DKFZ), Acute myeloid leukaemia.
Shares Deutsches Netzwerk für Personalisierte Medizin, Chronic lymphocytic leukaemia, Acute myeloid leukaemia.
Shares German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), PSMA PET, Prostate cancer.
Shares German Cancer Consortium (DKTK), Deutsches Netzwerk für Personalisierte Medizin, German Cancer Research Center (DKFZ), Acute myeloid leukaemia.
Shares German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Colorectal cancer.
Shares PSMA PET, IMRT / IGRT (modern external beam), Prostate cancer.
Shares German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), PSMA PET, Acute myeloid leukaemia.